
Niloofar Rahmani
Examiner (ID: 12602, Phone: (571)272-4329 , Office: P/1625 )
| Most Active Art Unit | 1625 |
| Art Unit(s) | 1625, 1691, 1621 |
| Total Applications | 2303 |
| Issued Applications | 1739 |
| Pending Applications | 128 |
| Abandoned Applications | 466 |
Applications
| Application number | Title of the application | Filing Date | Status |
|---|---|---|---|
Array
(
[id] => 9422422
[patent_doc_number] => 20140107073
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2014-04-17
[patent_title] => 'GDF-8 Inhibitors'
[patent_app_type] => utility
[patent_app_number] => 14/046834
[patent_app_country] => US
[patent_app_date] => 2013-10-04
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 115717
[patent_no_of_claims] => 39
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 14046834
[rel_patent_id] =>[rel_patent_doc_number] =>) 14/046834 | GDF-8 inhibitors | Oct 3, 2013 | Issued |
Array
(
[id] => 9295380
[patent_doc_number] => 20140039014
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2014-02-06
[patent_title] => 'HYDROXYBENZOATE SALTS OF METANICOTINE COMPOUNDS'
[patent_app_type] => utility
[patent_app_number] => 14/044914
[patent_app_country] => US
[patent_app_date] => 2013-10-03
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 15634
[patent_no_of_claims] => 5
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 14044914
[rel_patent_id] =>[rel_patent_doc_number] =>) 14/044914 | Hydroxybenzoate salts of metanicotine compounds | Oct 2, 2013 | Issued |
Array
(
[id] => 9295321
[patent_doc_number] => 20140038955
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2014-02-06
[patent_title] => 'HETEROARYL AMIDE ANALOGUES AS P2X7 ANTAGONISTS'
[patent_app_type] => utility
[patent_app_number] => 14/043861
[patent_app_country] => US
[patent_app_date] => 2013-10-02
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 30554
[patent_no_of_claims] => 18
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 14043861
[rel_patent_id] =>[rel_patent_doc_number] =>) 14/043861 | HETEROARYL AMIDE ANALOGUES AS P2X7 ANTAGONISTS | Oct 1, 2013 | Abandoned |
Array
(
[id] => 10381893
[patent_doc_number] => 20150266899
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2015-09-24
[patent_title] => 'ANTI-FIBROTIC PYRIDINONES'
[patent_app_type] => utility
[patent_app_number] => 14/432881
[patent_app_country] => US
[patent_app_date] => 2013-10-01
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 107480
[patent_no_of_claims] => 303
[patent_no_of_ind_claims] => 106
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 14432881
[rel_patent_id] =>[rel_patent_doc_number] =>) 14/432881 | ANTI-FIBROTIC PYRIDINONES | Sep 30, 2013 | Abandoned |
Array
(
[id] => 10642524
[patent_doc_number] => 09359379
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2016-06-07
[patent_title] => 'Anti-fibrotic pyridinones'
[patent_app_type] => utility
[patent_app_number] => 14/043121
[patent_app_country] => US
[patent_app_date] => 2013-10-01
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 107219
[patent_no_of_claims] => 21
[patent_no_of_ind_claims] => 5
[patent_words_short_claim] => 5
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 14043121
[rel_patent_id] =>[rel_patent_doc_number] =>) 14/043121 | Anti-fibrotic pyridinones | Sep 30, 2013 | Issued |
Array
(
[id] => 9538417
[patent_doc_number] => 20140163063
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2014-06-12
[patent_title] => 'QUINOLINONE-CARBOXAMIDE COMPOUNDS AS 5-HT4 RECEPTOR AGONISTS'
[patent_app_type] => utility
[patent_app_number] => 14/043585
[patent_app_country] => US
[patent_app_date] => 2013-10-01
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 25848
[patent_no_of_claims] => 12
[patent_no_of_ind_claims] => 3
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 14043585
[rel_patent_id] =>[rel_patent_doc_number] =>) 14/043585 | Quinolinone-carboxamide compounds as 5-HT4 receptor agonists | Sep 30, 2013 | Issued |
Array
(
[id] => 10506115
[patent_doc_number] => 09233979
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2016-01-12
[patent_title] => 'Compounds that are ERK inhibitors'
[patent_app_type] => utility
[patent_app_number] => 14/431462
[patent_app_country] => US
[patent_app_date] => 2013-09-26
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 88983
[patent_no_of_claims] => 16
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 6
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 14431462
[rel_patent_id] =>[rel_patent_doc_number] =>) 14/431462 | Compounds that are ERK inhibitors | Sep 25, 2013 | Issued |
Array
(
[id] => 10361907
[patent_doc_number] => 20150246912
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2015-09-03
[patent_title] => 'Pyrrolo[3,2-C]Pyridine Tropomyosin-Related Kinase Inhibitors'
[patent_app_type] => utility
[patent_app_number] => 14/430286
[patent_app_country] => US
[patent_app_date] => 2013-09-26
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 49073
[patent_no_of_claims] => 14
[patent_no_of_ind_claims] => 4
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 14430286
[rel_patent_id] =>[rel_patent_doc_number] =>) 14/430286 | Pyrrolo[3,2-c]pyridine tropomyosin-related kinase inhibitors | Sep 25, 2013 | Issued |
Array
(
[id] => 10498532
[patent_doc_number] => 09226922
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2016-01-05
[patent_title] => 'Compounds that are ERK inhibitors'
[patent_app_type] => utility
[patent_app_number] => 14/431485
[patent_app_country] => US
[patent_app_date] => 2013-09-26
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 83248
[patent_no_of_claims] => 15
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 6
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 14431485
[rel_patent_id] =>[rel_patent_doc_number] =>) 14/431485 | Compounds that are ERK inhibitors | Sep 25, 2013 | Issued |
Array
(
[id] => 10381863
[patent_doc_number] => 20150266870
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2015-09-24
[patent_title] => 'MULTIPLE KINASE PATHWAY INHIBITORS'
[patent_app_type] => utility
[patent_app_number] => 14/431476
[patent_app_country] => US
[patent_app_date] => 2013-09-25
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 11
[patent_figures_cnt] => 11
[patent_no_of_words] => 113208
[patent_no_of_claims] => 24
[patent_no_of_ind_claims] => 6
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 14431476
[rel_patent_id] =>[rel_patent_doc_number] =>) 14/431476 | Multiple kinase pathway inhibitors | Sep 24, 2013 | Issued |
Array
(
[id] => 10541746
[patent_doc_number] => 09266857
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2016-02-23
[patent_title] => 'Bicyclic AZA compounds as muscarinic M1 receptor agonists'
[patent_app_type] => utility
[patent_app_number] => 14/428927
[patent_app_country] => US
[patent_app_date] => 2013-09-18
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 1
[patent_figures_cnt] => 1
[patent_no_of_words] => 26634
[patent_no_of_claims] => 14
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 7
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 14428927
[rel_patent_id] =>[rel_patent_doc_number] =>) 14/428927 | Bicyclic AZA compounds as muscarinic M1 receptor agonists | Sep 17, 2013 | Issued |
Array
(
[id] => 11060714
[patent_doc_number] => 20160257676
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2016-09-08
[patent_title] => 'Aminoisoquinoline Derivatives as Protein Kinase Inhibitors'
[patent_app_type] => utility
[patent_app_number] => 14/428183
[patent_app_country] => US
[patent_app_date] => 2013-09-12
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 17064
[patent_no_of_claims] => 44
[patent_no_of_ind_claims] => 3
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 14428183
[rel_patent_id] =>[rel_patent_doc_number] =>) 14/428183 | Aminoisoquinoline Derivatives as Protein Kinase Inhibitors | Sep 11, 2013 | Abandoned |
Array
(
[id] => 11773405
[patent_doc_number] => 09382244
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2016-07-05
[patent_title] => '7-azaindole-2,7-naphthyridine derivative for the treatment of tumours'
[patent_app_type] => utility
[patent_app_number] => 14/432767
[patent_app_country] => US
[patent_app_date] => 2013-09-09
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 12234
[patent_no_of_claims] => 8
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 19
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 14432767
[rel_patent_id] =>[rel_patent_doc_number] =>) 14/432767 | 7-azaindole-2,7-naphthyridine derivative for the treatment of tumours | Sep 8, 2013 | Issued |
Array
(
[id] => 9212501
[patent_doc_number] => 20140011677
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2014-01-09
[patent_title] => 'HERBICIDAL COMPOUNDS'
[patent_app_type] => utility
[patent_app_number] => 14/020424
[patent_app_country] => US
[patent_app_date] => 2013-09-06
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 23479
[patent_no_of_claims] => 24
[patent_no_of_ind_claims] => 3
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 14020424
[rel_patent_id] =>[rel_patent_doc_number] =>) 14/020424 | Herbicidal compounds | Sep 5, 2013 | Issued |
Array
(
[id] => 9205993
[patent_doc_number] => 20140005170
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2014-01-02
[patent_title] => 'INDAZOLE INHIBITORS OF THE WNT SIGNAL PATHWAY AND THERAPEUTIC USES THEREOF'
[patent_app_type] => utility
[patent_app_number] => 14/019940
[patent_app_country] => US
[patent_app_date] => 2013-09-06
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 35503
[patent_no_of_claims] => 30
[patent_no_of_ind_claims] => 3
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 14019940
[rel_patent_id] =>[rel_patent_doc_number] =>) 14/019940 | Indazole inhibitors of the Wnt signal pathway and therapeutic uses thereof | Sep 5, 2013 | Issued |
Array
(
[id] => 9254712
[patent_doc_number] => 08618128
[patent_country] => US
[patent_kind] => B1
[patent_issue_date] => 2013-12-31
[patent_title] => '1H-pyrazolo[3,4-b]pyridines and therapeutic uses thereof'
[patent_app_type] => utility
[patent_app_number] => 14/019147
[patent_app_country] => US
[patent_app_date] => 2013-09-05
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 52987
[patent_no_of_claims] => 30
[patent_no_of_ind_claims] => 4
[patent_words_short_claim] => 12
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 14019147
[rel_patent_id] =>[rel_patent_doc_number] =>) 14/019147 | 1H-pyrazolo[3,4-b]pyridines and therapeutic uses thereof | Sep 4, 2013 | Issued |
Array
(
[id] => 9206029
[patent_doc_number] => 20140005206
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2014-01-02
[patent_title] => 'INDAZOLE INHIBITORS OF THE WNT SIGNAL PATHWAY AND THERAPEUTIC USES THEREOF'
[patent_app_type] => utility
[patent_app_number] => 14/019103
[patent_app_country] => US
[patent_app_date] => 2013-09-05
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 17986
[patent_no_of_claims] => 20
[patent_no_of_ind_claims] => 4
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 14019103
[rel_patent_id] =>[rel_patent_doc_number] =>) 14/019103 | Indazole inhibitors of the Wnt signal pathway and therapeutic uses thereof | Sep 4, 2013 | Issued |
Array
(
[id] => 11790067
[patent_doc_number] => 09399639
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2016-07-26
[patent_title] => 'Substituted azaindole compounds, salts, pharmaceutical compositions thereof and methods of use'
[patent_app_type] => utility
[patent_app_number] => 13/975371
[patent_app_country] => US
[patent_app_date] => 2013-08-26
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 35749
[patent_no_of_claims] => 14
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 6
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 13975371
[rel_patent_id] =>[rel_patent_doc_number] =>) 13/975371 | Substituted azaindole compounds, salts, pharmaceutical compositions thereof and methods of use | Aug 25, 2013 | Issued |
Array
(
[id] => 10567362
[patent_doc_number] => 09290517
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2016-03-22
[patent_title] => 'Azabenzimidazole hexahydrofuro[3,2-b]furan derivatives'
[patent_app_type] => utility
[patent_app_number] => 14/419774
[patent_app_country] => US
[patent_app_date] => 2013-08-19
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 95259
[patent_no_of_claims] => 20
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 7
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 14419774
[rel_patent_id] =>[rel_patent_doc_number] =>) 14/419774 | Azabenzimidazole hexahydrofuro[3,2-b]furan derivatives | Aug 18, 2013 | Issued |
Array
(
[id] => 9413830
[patent_doc_number] => 08697867
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2014-04-15
[patent_title] => 'Cross-linked cyclic amine compounds and agents for pest control'
[patent_app_type] => utility
[patent_app_number] => 13/967872
[patent_app_country] => US
[patent_app_date] => 2013-08-15
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 21534
[patent_no_of_claims] => 4
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 8
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 13967872
[rel_patent_id] =>[rel_patent_doc_number] =>) 13/967872 | Cross-linked cyclic amine compounds and agents for pest control | Aug 14, 2013 | Issued |